Skip to Content

LIQUIVISC TM 2.5MG/G EYE GEL

Active substance(s): CARBOMER

View full screen / Print PDF » Download PDF ⇩
Transcript
LIQUIVISC™

Package leaflet :
information for the user
In this leaflet:
1. What LIQUIVISC is and
what it is used for
2. Before you use
LIQUIVISC
3. How to use LIQUIVISC
4. Possible side effects
5. How to store LIQUIVISC
6. Further information

2.5 mg/g, eye gel
Carbomer 974P

eyes not producing enough
tears.
2.BEFORE YOU USE
LIQUIVISC

Do NOT use LIQUIVISC:
• if you are allergic
(hypersensitive) to
Carbomer or any of
the other ingredients
1.WHAT LIQUIVISC IS AND
of LIQUIVISC listed
WHAT IT IS USED FOR
in Section 6, “What
LIQUIVISC contains”.
LIQUIVISC is a substitute
for tears and contains a
Take special care with
lubricant called Carbomer
LIQUIVISC:
974P.
• if you wear soft contact
It is an eye gel used for the
lenses: you must
relief of the symptoms of
remove them before
dry eye (such as soreness,
using LIQUIVISC eye gel.
burning, irritation or
After using LIQUIVISC,
dryness) caused by your
wait at least 30 minutes

before putting your
lenses back in. See also
in Section 2, “Important
information about some
of the ingredients of
LIQUIVISC”.
• if your condition
worsens or has not
improved after having
started treatment with
LIQUIVISC: Contact your
doctor.
• DO NOT INJECT, DO NOT
SWALLOW.
Children and adolescents
aged to 18 years:
The safety and efficacy of
LIQUIVISC in children and
adolescents at the posology
recommended in adults has
been established by clinical

Read all of this leaflet carefully because it contains important information for you.
This medicine is available without prescription. However, you still need to use LIQUIVISC carefully to
get the best results from it.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more information or advice.
- You must contact a doctor if your symptoms worsen or do not improve.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.

experience, but no clinical
trial data are available.
Using other medicines
Please tell your doctor or
pharmacist if you are taking
or have recently taken any
other medicines, including
medicines obtained without
a prescription.
If you have to use any
other eye medicine during
treatment with LIQUIVISC:
first use the other eye
medicine, wait 15 minutes,
then use LIQUIVISC.
Pregnancy
and breast-feeding
If you are pregnant or
breast-feeding, contact
your doctor for advice

before you start using
LIQUIVISC.
He/she will decide if you
can use LIQUIVISC.

to wait at least 30 minutes
before putting your lenses
back in.
This is important because
one of the ingredients
of LIQUIVISC, called
benzalkonium chloride,
may cause eye irritation
and can change the colour
of soft contact lenses.

Driving and using
machines
Your sight may become
blurred for a short time
just after using LIQUIVISC.
You should not drive or use
machines until your sight is 3.HOW TO USE LIQUIVISC
clear again.
If LIQUIVISC has been
recommended for you
Important information
then use it exactly as your
about some of the
doctor has told you. You
ingredients of LIQUIVISC
should check with your
If you wear soft contact
doctor or pharmacist if you
lenses you must remove
are not sure.
them before using
LIQUIVISC eye gel. After
The usual dose of
using LIQUIVISC, you have
LIQUIVISC is 1 drop

XXXXX
XXXXX

XXXXX
XXXXX

in each eye that needs
treatment, up to 4 times a
day.
Children and adolescents
aged to 18 years:
The safety and efficacy of
LIQUIVISC in children and
adolescents at the posology
recommended in adults has
been established by clinical
experience, but no clinical
trial data are available.
Instructions for use
Do not use the bottle if
the seal around the cap
is broken before you first
open it.

Turn over

XXXXX
XXXXX
Gently pull
down the
lower eyelid
of the eye
that needs
treatment
until there
is a small
“pocket”.

2.

Turn the bottle
upside down.
Squeeze it
to release
1 drop into the
“pocket”.

3.

4.

00.0000

Let go of the
lower lid, and
blink your
eyes a few
times.
Repeat the
steps 1 to
3 for the
other eye, if
it also needs
treatment.

If you forget to use
or feeling of burning in the
LIQUIVISC
eye.
If you have missed a dose
Tilt your head back and
The above mentioned side
of LIQUIVISC continue with
look at the ceiling.
effects are known to occur,
your next dose as normal.
but the number of people
To help prevent infection,
If you have any further
likely to be affected can vary.
do not let the tip of the
questions on the use of this
bottle touch your eye,
Reporting of side effects
product, ask your doctor or
the surrounding tissue or
If you get any side effects,
pharmacist.
anything else.
talk to your doctor or
4.POSSIBLE SIDE
pharmacist. This includes
Put the screw cap back on
EFFECTS
any possible side effects
to close the bottle, straight
not listed in this leaflet. You
after you have used it.
Like all medicines,
can also report side effects
Store the bottle in an
LIQUIVISC can cause
directly via:
upside down position as
side effects, although not
this helps drops to form
UK
everybody gets them.
the next time you use
The Yellow Card Scheme.
Contact your doctor if:
LIQUIVISC.
Website: www.mhra.gov.
• your condition worsens
uk/yellowcard
Once you have opened the
or has not improved after
bottle, you must not use
having started treatment Ireland
it longer than 28 days;
HPRA Pharmacovigilance
with LIQUIVISC.
please see also Section 5,
Earlsfort Terrace
If you experience any of the
“How to store LIQUIVISC”.
IRL – Dublin 2
following side effects just
Tel: +353 1 676 4971
If you use more LIQUIVISC after putting in the eye gel,
Fax: +353 1 676 2517
than you should
talk to your doctor if they
Website: www.hpra.ie
Using more drops of
worry you:
e-mail: medsafety@hpra.ie
LIQUIVISC than you should • short-lived blurring of
will not cause you any harm.
By reporting side effects
vision
you can help provide more
• mild short-lived stinging
Wash your hands before
opening the bottle.

information on the safety of your pharmacist how to
this medicine.
dispose of medicines no
longer required. These
5.HOW TO STORE
measures will help to
LIQUIVISC
protect the environment.
Keep out of the reach and
6. FURTHER INFORMATION
sight of children.
What LIQUIVISC contains
Do not use LIQUIVISC after
• The active ingredient
the expiry date which is
is Carbomer 974P
stated on the bottle label
2.5 mg/g.
and the carton after ‘EXP.’.
• The other ingredients
The expiry date refers to
are benzalkonium
the last day of that month.
chloride, sorbitol, lysine
Do not store above 25°C.
monohydrate, sodium
Keep the bottle in the outer
acetate trihydrate,
carton in order to protect
polyvinyl alcohol, water
from light. Store the bottle
for injections.
in an upside down position
What LIQUIVISC looks like
as this helps drops to
and contents of the pack
form the next time you use
LIQUIVISC is a slightly
LIQUIVISC.
yellow opalescent gel in a
You must throw away the plastic bottle with a screwbottle 28 days after you
cap.
first opened it, even if there Each bottle contains 10 g of
are still some drops left.
eye gel.
Each pack contains 1 bottle.
Medicines should not be
disposed of via wastewater Marketing Authorisation
or household waste. Ask
Holder and Manufacturer

XXXXX
XXXXX

1.

Marketing Authorisation
Holder:
Laboratoires Théa
12 rue Louis Blériot
63017 Clermont-Ferrand
Cedex 2 FRANCE
Manufacturer:
URSAPHARM, Arzneimittel
GmbH
Industriestrasse
66129 Saarbrücken
Germany
This medicinal product is
authorised in the Member
States of the EEA under the
following names:
France, Spain, Italy,
Portugal, The Netherlands
and Greece: .....SICCAFLUID
United Kingdom and
Ireland:...............LIQUIVISC
Iceland and Norway: ..........
.............................OFTAGEL
This leaflet was last
approved in 03/2015.
PL 20162/0009
PA 1107/2/1

N830G10ASP-2-Bis

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide